Romania has once again proved fertile ground for Swissray, which is selling the Romanian government 30 ddRChest-Systems for more than $7 million, in addition to the 32 ddRMulti-Systems delivered earlier this year for $13.8 million.Swissray reported its
Romania has once again proved fertile ground for Swissray, which is selling the Romanian government 30 ddRChest-Systems for more than $7 million, in addition to the 32 ddRMulti-Systems delivered earlier this year for $13.8 million.
Swissray reported its first-ever positive cash flow from operating activities (SCAN, 10/11/00). The Switzerland-based company said it has sold or contracted for more than 100 ddR systems worldwide. The company hopes to surpass this figure in 2001.
Swissray was delisted from the NASDAQ stock exchange in 1998 after its stock steadily declined to a per-share price below $1. With sales now climbing, the company hopes to be relisted soon.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Study Shows Enhanced Diagnosis of Coronary Artery Stenosis with Photon-Counting CTA
July 10th 2025In a new study comparing standard resolution and ultra-high resolution modes for patients undergoing coronary CTA with photon-counting detector CT, researchers found that segment-level sensitivity and accuracy rates for diagnosing coronary artery stenosis were consistently > 89.6 percent.
FDA Expands Approval of MRI-Guided Ultrasound Treatment for Patients with Parkinson’s Disease
July 9th 2025For patients with advanced Parkinson’s disease, the expanded FDA approval of the Exablate Neuro platform allows for the use of MRI-guided focused ultrasound in performing staged bilateral pallidothalamic tractotomy.